Epilepsy Therapy Project

Funding Agency:
Epilepsy Foundation

The Epilepsy Therapy Project of the Epilepsy Foundation accelerates ideas into therapies for people living with epilepsy and seizures.

Founded in 2002 by Warren Lammert and Orrin Devinsky MD, the Epilepsy Therapy Project merged with the Epilepsy Foundation in 2012. The vision is to foster innovation and support scientific advancements that could result in new treatments for people with epilepsy. Most importantly, we want to get new therapies to people with epilepsy faster – in a timeframe that matters!

The Epilepsy Therapy Project fulfills this by:

  • Promoting partnerships among industry, academia, investors, and physicians
  • Providing financial support to advance promising science that could lead to better therapies
  • Fostering innovation and entrepreneurship so novel epilepsy projects and companies can make it to people with epilepsy
  • Providing visibility to therapies and devices in the epilepsy pipeline and increase attention to the real needs of people with epilepsy and the need for more research efforts


Agency Website

Areas of Interest

Key Epilepsy Therapy Project Programs

New Therapy Commercialization Grants: We fund new, innovative research from leading scientists and startup companies. Focus is on accelerating the progress of breakthrough research and new therapies "from the bench to the bedside.” Grants are up to $350,000, over a two-year period, and are awarded twice a year.Full Grant Proposal due January 7, 2020

Epilepsy Innovation Seal Of Excellence Award: We provide a seal of approval that certifies that a specific epilepsy-related company meets the Epilepsy Foundation’s standards of excellence. The program provides a competitive, in-depth review by the Scientific and Business Advisory Boards, a SEAL that may be used by the awardee to generate interest in the project. Full Grant Proposal due January 7, 2020

Funding Type



Junior Faculty
Medical Fellow/Resident
Post Doctoral Fellows


Medical - Clinical Science
Medical - Translational

External Deadline

January 7, 2020